Lipidomics Point to Obesity–Alzheimer's Link - Scorecard - MDSpire

Lipidomics Point to Obesity–Alzheimer's Link

Study uses multi-omics tools to examine obesity-related pathways linked to neurodegeneration

  • May 26, 2026

  • 2 min

Share

Clinical Scorecard: Lipidomics Point to Obesity–Alzheimer's Link

At a Glance

CategoryDetail
ConditionAlzheimer's Disease (AD)
Key MechanismsObesity-related changes in lipid metabolism, specifically phosphatidylethanolamine (PE) accumulation.
Target PopulationIndividuals with obesity and Alzheimer's disease.
Care SettingResearch settings, primarily using mouse models.

Key Highlights

  • Obesity linked to increased PE accumulation in brain and peripheral tissues.
  • Disrupted immune signaling and altered microglial function observed.
  • Treatment with ebselen reduced lipid abnormalities and improved cognitive performance.
  • Lipidomics and multi-omics technologies are pivotal in neurodegenerative research.
  • Obesity-associated lipid signatures may aid future biomarker research.

Guideline-Based Recommendations

Diagnosis

  • Current AD diagnostics focus on amyloid and tau biomarkers.

Management

  • Further studies needed to explore PE dysregulation targeting.

Monitoring & Follow-up

  • Potential for PE-related lipid alterations in therapeutic monitoring.

Risks

  • Obesity-associated metabolic dysfunction may accelerate AD processes.

Patient & Prescribing Data

Individuals with obesity and Alzheimer's disease.

Ebselen may modify lipid abnormalities and improve neuroimmune signaling.

Clinical Best Practices

  • Utilize advanced laboratory technologies like lipidomics for studying neurodegeneration.
  • Consider obesity-related lipid signatures in future biomarker research.

Related Resources & Content

Original Source(s)

Lipidomics Point to Obesity–Alzheimer's Link

  • May 26, 2026

Related Content

MRI May Define Two Distinct Migraine Phenotypes

Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.

  • by

  • May 21, 2026

  • 1 min
Baptist Health Foundation Presents Endowed Chair Ceremony for Aviva Abosch, M.D., Ph.D.

Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.

  • by

  • May 21, 2026

  • 5 min